Cerebellar tDCS in Children With Autism Spectrum Disorder
NCT: NCT04446442 · RECRUITING
Brief Summary
The purpose of this research study is to investigate whether tDCS to the cerebellum (specifically, the right crus I/II area of the cerebellum) of children and young adults with autism spectrum disorders (ASD) is safe and to examine its effects on some of the symptoms of ASD, such as repetitive behaviors and hyperactivity.
Frequently Asked Questions
What is Cerebellar tDCS in Children With Autism Spectrum Disorder?
Cerebellar tDCS in Children With Autism Spectrum Disorder is a clinical trial registered under NCT04446442. Current status: RECRUITING.
What is the status of NCT04446442?
The current status of NCT04446442 (Cerebellar tDCS in Children With Autism Spectrum Disorder) is: RECRUITING.
When did Cerebellar tDCS in Children With Autism Spectrum Disorder start?
Cerebellar tDCS in Children With Autism Spectrum Disorder started on 2019-06-04.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.